Vaccine
Volume 28, Issue 37  pp. 5931-6122 (23 August 2010)

Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza Original Research Article
Pages 5952-5959
Bruce Y. Lee, Rachel R. Bailey, Ann E. Wiringa, Abena Afriyie, Angela R. Wateska, Kenneth J. Smith, Richard K. Zimmerman

Abstract
Employers may be loath to fund vaccination programs without understanding the economic consequences. We developed a decision analytic computational simulation model including dynamic transmission elements that estimated the cost–benefit of employer-sponsored workplace vaccination from the employer’s perspective. Implementing such programs was relatively inexpensive (<$35/vaccinated employee) and, in many cases, cost saving across diverse occupational groups in all seasonal influenza scenarios. Such programs were cost-saving for a 20% serologic attack rate pandemic scenario (range: −$15 to −$995) per vaccinated employee) and a 30% serologic attack rate pandemic scenario (range: −$39 to −$1,494 per vaccinated employee) across all age and major occupational groups.